HBC-00015875

N/A

Report date: 2026/02/10 20:00:22
NME

Base Information

Drug NameHBC-00015875
Drug Alias NameHBC-00015875HBC00015875
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN inhibitors
TargetsBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Therapy Area/IndicationsMicrosatellite instability-high cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Hansoh Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Hansoh Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsMicrosatellite instability-high cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A